{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:16:08Z","timestamp":1790324168226,"version":"4.1.0"},"reference-count":7,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.3201\/eid0501.990118","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T17:10:29Z","timestamp":1253034629000},"page":"147-149","source":"Crossref","is-referenced-by-count":118,"title":["<i>Staphylococcus aureus<\/i> with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal Bacteremia"],"prefix":"10.3201","volume":"5","author":[{"given":"Sharon S.","family":"Rotun","sequence":"first","affiliation":[{"name":"United Hospital Medical Center (UHMC), Port Chester, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"McMath","sequence":"additional","affiliation":[{"name":"United Hospital Medical Center (UHMC), Port Chester, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna J.","family":"Schoonmaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy S.","family":"Maupin","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.","family":"Tenover","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertha C.","family":"Hill","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ackman","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid0501.990118-202410171001-R1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid0501.990118-202410171001-R2","first-page":"765","article-title":"Staphylococcus aureus with reduced susceptibility to vancomycin\u2014United States.","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0501.990118-202410171001-R3","unstructured":"Etest package insert. AB Biodisk North America., Piscataway, NJ. 1996."},{"key":"key-10.3201\/eid0501.990118-202410171001-R4","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Vol 17, no. 2, Approved Standard M7-A4, National Committee for Clinical Laboratory Standards, Wayne, PA. 1998."},{"key":"key-10.3201\/eid0501.990118-202410171001-R5","unstructured":"National Committee for Clinical Laboaratory Standards. Performance standards for antimicrobial disk susceptibility tests. 6th ed. Vol. 17, no. 1. Approved Standard M2-A6, National Committee for Clinical Laboratory Standards, Wayne, PA. 1998."},{"key":"key-10.3201\/eid0501.990118-202410171001-R6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/JCM.36.4.1020-1027.1998","article-title":"Characterization of Staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.","volume":"36","author":"Tenover","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid0501.990118-202410171001-R7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/infdis\/166.5.1066","article-title":"Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility.","volume":"166","author":"Daum","year":"1992","journal-title":"J Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/5\/1\/99-0118_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T01:22:02Z","timestamp":1732584122000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/5\/1\/99-0118_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid0501.990118","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}